Search research articles
Contact Us
Filters
Showing results (601-610 of 716) with videos related to
Page
of 72
Sort By:
Journal of the American College of Cardiology
|
May 16, 2006
Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue doppler imaging and velocity-encoded magnetic resonance imaging
Jos J M Westenberg, Hildo J Lamb, Rob J van der Geest, et al.
Diabetes Care
|
August 4, 2018
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
John M Dennis, William E Henley, Michael N Weedon, et al.
Circulation
|
February 27, 2020
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
M Angelyn Bethel, Susanna R Stevens, John B Buse, et al.
Diabetes Care
|
May 20, 2026
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study
Katherine G Young, Andrew P McGovern, Rhian Hopkins, et al.
Cardiovascular Diabetology
|
October 24, 2019
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
Lindsay E Clegg, Robert C Penland, Srinivas Bachina, et al.
Diabetes Care
|
December 7, 2019
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Shelby D Reed, Yanhong Li, Helen A Dakin, et al.
Journal of Medicinal Chemistry
|
April 2, 2014
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies
Ganesha Rai, Netra Joshi, Joo Eun Jung, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 23, 2011
Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma
Randa M Abdulrahman, Victoria Delgado, Hendrieke C Hoftijzer, et al.
Lancet (London, England)
|
December 24, 2013
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
Thomas Yates, Steven M Haffner, Phillip J Schulte, et al.
Metabolism: Clinical and Experimental
|
February 25, 2014
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR
Kim M Huffman, Jie-Lena Sun, Laine Thomas, et al.
Page
of 72
Search research articles
Search
Showing results (601-610 of 716) with videos related to
Sort By:
Page
of 72
Journal of the American College of Cardiology
|
May 16, 2006
Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue doppler imaging and velocity-encoded magnetic resonance imaging
Jos J M Westenberg, Hildo J Lamb, Rob J van der Geest, et al.
Diabetes Care
|
August 4, 2018
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
John M Dennis, William E Henley, Michael N Weedon, et al.
Circulation
|
February 27, 2020
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
M Angelyn Bethel, Susanna R Stevens, John B Buse, et al.
Diabetes Care
|
May 20, 2026
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study
Katherine G Young, Andrew P McGovern, Rhian Hopkins, et al.
Cardiovascular Diabetology
|
October 24, 2019
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
Lindsay E Clegg, Robert C Penland, Srinivas Bachina, et al.
Diabetes Care
|
December 7, 2019
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Shelby D Reed, Yanhong Li, Helen A Dakin, et al.
Journal of Medicinal Chemistry
|
April 2, 2014
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies
Ganesha Rai, Netra Joshi, Joo Eun Jung, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 23, 2011
Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma
Randa M Abdulrahman, Victoria Delgado, Hendrieke C Hoftijzer, et al.
Lancet (London, England)
|
December 24, 2013
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
Thomas Yates, Steven M Haffner, Phillip J Schulte, et al.
Metabolism: Clinical and Experimental
|
February 25, 2014
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR
Kim M Huffman, Jie-Lena Sun, Laine Thomas, et al.
Page
of 72